rs2412000
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_024652.6(LRRK1):c.753G>A(p.Pro251=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.065 in 1,613,942 control chromosomes in the GnomAD database, including 6,577 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 2430 hom., cov: 33)
Exomes 𝑓: 0.058 ( 4147 hom. )
Consequence
LRRK1
NM_024652.6 synonymous
NM_024652.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.99
Genes affected
LRRK1 (HGNC:18608): (leucine rich repeat kinase 1) This gene encodes a multi-domain protein that is a leucine-rich repeat kinase and a GDP/GTP binding protein. The encoded protein is thought to play a role in the regulation of bone mass. Mice lacking a similar gene showed severe osteopetrosis, increased bone mineralization and decreased bone resorption. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 15-100989389-G-A is Benign according to our data. Variant chr15-100989389-G-A is described in ClinVar as [Benign]. Clinvar id is 1636917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.99 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRK1 | NM_024652.6 | c.753G>A | p.Pro251= | synonymous_variant | 6/34 | ENST00000388948.8 | NP_078928.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRK1 | ENST00000388948.8 | c.753G>A | p.Pro251= | synonymous_variant | 6/34 | 5 | NM_024652.6 | ENSP00000373600 | P1 | |
LRRK1 | ENST00000532029.6 | c.753G>A | p.Pro251= | synonymous_variant | 6/6 | 1 | ENSP00000433268 | |||
LRRK1 | ENST00000525284.5 | c.753G>A | p.Pro251= | synonymous_variant, NMD_transcript_variant | 5/33 | 1 | ENSP00000433069 | |||
LRRK1 | ENST00000531270.5 | c.753G>A | p.Pro251= | synonymous_variant, NMD_transcript_variant | 5/32 | 1 | ENSP00000431668 |
Frequencies
GnomAD3 genomes AF: 0.127 AC: 19305AN: 152112Hom.: 2423 Cov.: 33
GnomAD3 genomes
AF:
AC:
19305
AN:
152112
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0645 AC: 16091AN: 249476Hom.: 1190 AF XY: 0.0615 AC XY: 8318AN XY: 135340
GnomAD3 exomes
AF:
AC:
16091
AN:
249476
Hom.:
AF XY:
AC XY:
8318
AN XY:
135340
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0585 AC: 85494AN: 1461712Hom.: 4147 Cov.: 32 AF XY: 0.0580 AC XY: 42142AN XY: 727158
GnomAD4 exome
AF:
AC:
85494
AN:
1461712
Hom.:
Cov.:
32
AF XY:
AC XY:
42142
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.127 AC: 19357AN: 152230Hom.: 2430 Cov.: 33 AF XY: 0.123 AC XY: 9132AN XY: 74436
GnomAD4 genome
AF:
AC:
19357
AN:
152230
Hom.:
Cov.:
33
AF XY:
AC XY:
9132
AN XY:
74436
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
231
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
LRRK1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at